During the past decade, Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 5 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 5 clinical trials were completed. i.e. 17.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University" #1 sponsor was "The Second Hospital of Nanjing Medical University" with 24 trials, followed by "Hoffmann-La Roche" with 13 trials sponsored, "The First Affiliated Hospital with Nanjing Medical University" with 11 trials sponsored, "Kawin Technology Share-holding Co., Ltd." with 3 trials sponsored and "Nanjing First Hospital, Nanjing Medical University" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University" #1 collaborator was "Air Force Military Medical University, China" with 3 trials as a collaborator, "KawinGreen Biotech Co., Ltd." with 3 trials as a collaborator, "The First Affiliated Hospital of Guangdong Pharmaceutical University" with 2 trials as a collaborator, "Wuxi No. 2 People's Hospital" with 2 trials as a collaborator and "Daping Hospital and the Research Institute of Surgery of the Third Military Medical University" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University" are "Crohn's Diseases" (3 trials), "Hepatitis C, Chronic" (3 trials), "Ulcerative Colitis" (3 trials), "Cholangiocarcinoma" (2 trials) and "Diffuse Large B Cell Lymphoma" (2 trials). Many other conditions were trialed in "Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University" in a lesser frequency.

Most popular intervention types in "Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University" are "Drug" (37 trials), "Procedure" (12 trials), "Other" (7 trials), "Device" (4 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Placebo" (5 trials), "Paclitaxel" (3 trials), "Sofosbuvir" (3 trials) and "Atezolizumab Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University" are 54 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University". 6 are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, 7 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 18 trials that are defined as “Not Applicable".